Klaus Elenius

Turku, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies.

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies.

Journal: Molecular oncology

Published: July 04, 2025

Database of recurrent mutations, an unbiased web resource to browse recurrent mutations in cancers.

Database of recurrent mutations, an unbiased web resource to browse recurrent mutations in cancers.

Journal: iScience

Published: March 09, 2025

Novel Genetic Risk Variants Associated with Oral Tongue Squamous Cell Carcinoma.

Novel Genetic Risk Variants Associated with Oral Tongue Squamous Cell Carcinoma.

Journal: Head and neck pathology

Published: February 28, 2025

Signaling downstream of tumor-stroma interaction regulates mucinous colorectal adenocarcinoma apicobasal polarity.

Signaling downstream of tumor-stroma interaction regulates mucinous colorectal adenocarcinoma apicobasal polarity.

Journal: Nature communications

Published: September 20, 2024

Phosphoproteomic analysis reveals the diversity of signaling behind ErbB-inhibitor-induced phenotypes.

Phosphoproteomic analysis reveals the diversity of signaling behind ErbB-inhibitor-induced phenotypes.

Journal: The FEBS journal

Published: July 30, 2024

Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth In Vivo.

Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth In Vivo.

Journal: Chembiochem : a European journal of chemical biology

Published: March 21, 2024

DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer.

DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer.

Journal: EMBO molecular medicine

Published: September 04, 2023

De Novo Multi-Omics Pathway Analysis Designed for Prior Data Independent Inference of Cell Signaling Pathways.

De Novo Multi-Omics Pathway Analysis Designed for Prior Data Independent Inference of Cell Signaling Pathways.

Journal: Molecular & cellular proteomics : MCP

Published: July 07, 2023

Trans-activating mutations of the pseudokinase ERBB3.

Trans-activating mutations of the pseudokinase ERBB3.

Journal: Oncogene

Published: February 09, 2023

STAT5b is a key effector of NRG-1/ERBB4-mediated myocardial growth.

STAT5b is a key effector of NRG-1/ERBB4-mediated myocardial growth.

Journal: EMBO reports

Published: December 18, 2022

An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations.

An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations.

Journal: Cancer research communications

Published: August 10, 2021

Therapeutic Potential of Targeting the SUMO Pathway in Cancer.

Therapeutic Potential of Targeting the SUMO Pathway in Cancer.

Journal: Cancers

Published: August 05, 2021

Showing 1-12 of 49

Last Updated: 09/26/2026